Navigation Links
Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
Date:2/10/2009

SAN DIEGO, Feb. 10 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced that it has completed a $27.5 million initial closing of a Series D financing led by Investor Growth Capital. Other participating investors include RiverVest Venture Partners, as well as existing investors SV Life Sciences, HBM BioVentures, Aberdare Ventures and Adams Street Partners. These investors have made commitments to additional closings that could bring the total Series D financing to $40.0 million.

Mpex's lead product candidate, MP-376, is a proprietary aerosol formulation of the antibiotic levofloxacin which is being developed as a maintenance therapy for the prevention of bacterial exacerbations in patients with chronic respiratory infections. MP-376 is currently being evaluated in ongoing Phase 2 clinical trials in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).

"This new investment will enable us to complete the ongoing Phase 2 trials of MP-376 in both CF and COPD, as well as prepare for Phase 3 trials in these indications," said Daniel Burgess, President and Chief Executive Officer of Mpex. "We now have a very strong investor syndicate to help us advance these programs rapidly towards commercialization. We believe that this financing positions us well financially to achieve all of our development objectives for MP-376."

"MP-376 is a novel formulation of a proven antibiotic specifically designed for aerosol administration with a well-validated delivery system," said Sam Nickerson of Investor Growth Capital. "We are encouraged by the clinical data in CF patients to date and believe that if MP-376 is successful in reducing exacerbations in COPD patients, it will represent an important new therapy for this indication as well." In connection with the financing, Mr. Nickerson will join Mpex's board of directors.

CF is a hereditary disease affecting approximately 30,00
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Prism Pharmaceuticals Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology
2. Genesis Pharmaceuticals Successfully Defends Itself in a Multi-Million Dollar Arbitration, Two Other Arbitration Proceedings Against Genesis are Withdrawn
3. Pharmaceuticals sold in Sweden cause serious environmental harm in India
4. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
5. Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results
6. Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
8. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
9. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
10. MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... 2013 Rampant staph infections continue to ... this scourge is being successfully deployed by China's military: ... and by touching items that are contaminated such as ... by the San Francisco Chronicle , “It is ... during hospital stays, and at least 90,000 of them ...
(Date:6/20/2013)... During a June 13 panel discussion on health ... Benefit Exchange confirmed the existence of the Federal Data ... consider,” writes panel moderator Steve Davis in a ... and leprechauns.” , “We are the only state to ... live,” Rebecca Pearce told attendees at Gorman Health Group’s ...
(Date:6/20/2013)... NJ (PRWEB) June 20, 2013 As ... is volunteer assistance. Keeping volunteers motivated in a non-profit ... Kars4Kids , a the nation’s leading car donation charity ... network of over 1,000 individuals, has announced the best ... not only physically present, but mentally engaged as well. ...
(Date:6/20/2013)... Handgiftbox.com Mobile, a leading manufacturer and distributor of ... the launch of 16GB version of the Mini Studio ... high-performance, high-quality tablet that is a direct competitor to ... $256 but it will be launched at promotional price ... , The Mini STUDIO is part of the Handgiftbox.com ...
(Date:6/20/2013)... Phoenix, AZ (PRWEB) June 20, 2013 ... used recreational vehicle sales, warns campers that improperly handled food ... consequences. , Now that summertime has arrived, many RV campers ... al fresco. Whether they are eating outdoors at the campground ... food are ever present and should be avoided at all ...
Breaking Medicine News(10 mins):Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 2Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 3Health News:Federal Data Services Hub Does Exist, AISHealth.com Blog Post Reports 2Health News:Kars4kids Announces Tips on How to Keep Non-profit Volunteers Engaged, Passionate and Active 2Health News:Android Tablet PC Mini Studio with Android 4.1 with 16GB is Here at $121 Only at Handgiftbox.com 2Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 2Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 3
... 2007)Uninsured patients in publicly funded community health centers face ... a new study finds. Whats more, this is even ... patient does in fact need these services. Conversely, community ... easier time accessing services. , Often times, people ...
... Research here shows that an obscure form of RNA, ... an important role in human cancer. , These ultraconserved ... but a new report in the September issue of the ... case. , The study found that UCRs, like classic ...
... Calif., Sept. 11 Cepheid (Nasdaq:,CPHD) will present ... the St. Regis Hotel, San Francisco, on Sept. ... Chief Financial Officer, John Sluis will present,at 9:30 ... audio webcast of the presentation, along with,accompanying presentation ...
... Jacobs Engineering,Group Inc. (NYSE: JEC ) announced today ... provide owner-engineer support for a new 220-bed,53,000 square meter ... for cancer identification and treatment. Officials did not ... investment cost for the new hospital is over Euro ...
... Industries Corporation (OTC Pink Sheets: CBIU), a leading,company ... new,series of biological nanometer cosmetics products named "U-SOGNO" ... experiments. The,name comes from the Italian word -- ... -- "One,s Dreams Coming True." The new ...
... Availability of Monte Carlo Dose Calculation Software Announced ... European Radiation Oncology Meeting in Barcelona, BARCELONA, Spain, ... global leader in the field of radiosurgery,announced today that ... from the U.S. Food and Drug Administration and is,now ...
Cached Medicine News:Health News:Uninsured community health center patients often have difficulty accessing specialty services 2Health News:Uninsured community health center patients often have difficulty accessing specialty services 3Health News:New class of RNA molecules may be important in human cancer 2Health News:Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference 2Health News:Jacobs Receives Contract for New Hospital Project in Belgium 2Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 2Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 3Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 2Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 3Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 4Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 5
(Date:6/19/2013)... Calif. , June 19, 2013   ... improve sample standardization and handling in many areas ... issuance of new patents by the U.S. Patent ... thermo-conductive products developed to standardize sample handling to ... of results in common laboratory procedures. ...
(Date:6/19/2013)... BURLINGTON, Mass. , June 19, 2013 /PRNewswire/ ... and advisory firms for pharmaceutical and healthcare issues, ... the majority of surveyed U.S. and European rheumatologists ... of the attributes that most influences their prescribing ... U.S. and European rheumatologists, respectively, rank the percentage ...
(Date:6/19/2013)... /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX, "Chindex" or ... in China through the ... private hospitals and affiliated ambulatory clinics, today announced ... Rehabilitation Hospital ("BJU Rehab Hospital"), one of the ... ("UFH") network. On June 19, 2013, the Company ...
Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5
... ALSO TUES., MAY 25 NOON—RIBBON CUTTING –OPENING NEW CANYON PARK TREATMENT SOLUTIONS, ... WA 98021, Suite 101 , , , ... Announce 96% Successful Stop of Opiate Abuse within 30 Days Treatment , ... TACOMA, Wash. and BOTHELL, Wash. , May 18 Four- Star General ...
... 18 Accuray Incorporated (Nasdaq: ARAY ), a global leader in ... joined Accuray as General Manager of the EIMEA (Europe India Middle East and ... , , ... healthcare device and supply company, where he served most recently as the EMEA ...
Cached Medicine Technology:4-Star General-Former U.S. Drug Czar Barry McCaffrey Featured At Tacoma Treatment Solutions 5-Year Anniv: Mon. May 24, 11 a.m., 9500 Front Street, Lakewood WA 98499 24-Star General-Former U.S. Drug Czar Barry McCaffrey Featured At Tacoma Treatment Solutions 5-Year Anniv: Mon. May 24, 11 a.m., 9500 Front Street, Lakewood WA 98499 3Accuray Hires General Manager for the EIMEA Region 2Accuray Hires General Manager for the EIMEA Region 3Accuray Hires General Manager for the EIMEA Region 4
... is a non-invasive massage machine for ... the circulatory system. Extraordinary results are ... action, which combines vertical and parallel ... percussion, gyratory massage, deep tissue mobilization, ...
The Ritter 204 Manual Exam Table. Featuring the latest in design, comfort and functionality in a manual exam table, it truly offers efficient patient care....
... 622 and 623 High-Low Examination Tables deliver the ... you. Many different types of patients can ... how to get on the exam table. Being ... ,can increase a patients comfort during the exam, ...
... MegaPeel microdermabrasion systems offer many features that ... save you time and money. Because our ... easy to use and maintain, you spend ... your microdermabrasion equipment. MegaPeel microdermabrasion systems are ...
Medicine Products: